• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Large healthcare system evaluation of postoperative moxifloxacin ophthalmic solution cross-reactivity.

作者信息

Adams Kathleen K, Shah Sunish

机构信息

From the University of Connecticut School of Pharmacy, Storrs Mansfield, Connecticut (Adams); Department of Pharmacy, Yale New Haven Health, Department of Pharmacy Services, New Haven, Connecticut (Adams, Shah); Antimicrobial Management Program, University of Pittsburgh Medical Center, Pittsburgh, PA (Shah).

出版信息

J Cataract Refract Surg. 2022 Nov 1;48(11):1347-1348. doi: 10.1097/j.jcrs.0000000000001039.

DOI:10.1097/j.jcrs.0000000000001039
PMID:36026700
Abstract
摘要

相似文献

1
Large healthcare system evaluation of postoperative moxifloxacin ophthalmic solution cross-reactivity.大型医疗保健系统对术后莫西沙星滴眼液交叉反应性的评估。
J Cataract Refract Surg. 2022 Nov 1;48(11):1347-1348. doi: 10.1097/j.jcrs.0000000000001039.
2
The role of topical moxifloxacin, a new antibacterial in Europe, in the treatment of bacterial conjunctivitis.莫西沙星滴眼液在治疗细菌性结膜炎中的作用。
Clin Drug Investig. 2011;31(8):543-557. doi: 10.2165/11589020-000000000-00000.
3
Moxifloxacin 0.5% ophthalmic solution: in bacterial conjunctivitis.莫西沙星 0.5%滴眼液：治疗细菌性结膜炎。
Drugs. 2011 Jan 1;71(1):89-99. doi: 10.2165/11205840-000000000-00000.
4
Rate of bacterial eradication by ophthalmic solutions of fourth-generation fluoroquinolones.第四代氟喹诺酮类眼科制剂的细菌清除率。
Adv Ther. 2009 Apr;26(4):447-54. doi: 10.1007/s12325-009-0018-5. Epub 2009 Apr 16.
5
Fourth-generation fluoroquinolone penetration into the aqueous humor in humans.第四代氟喹诺酮类药物在人体房水中的渗透情况。
Ophthalmology. 2006 Jun;113(6):955-9. doi: 10.1016/j.ophtha.2006.01.061. Epub 2006 Apr 17.
6
Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis.0.6%贝西沙星眼用混悬液与0.5%莫西沙星滴眼液治疗细菌性结膜炎的疗效和安全性比较
Ophthalmology. 2009 Sep;116(9):1615-1623.e1. doi: 10.1016/j.ophtha.2009.05.014. Epub 2009 Jul 29.
7
Selecting between gatifloxacin and moxifloxacin drops in ambulatory ophthalmic surgery.门诊眼科手术中加替沙星滴眼液与莫西沙星滴眼液的选择
Am J Health Syst Pharm. 2006 Sep 1;63(17):1637-40. doi: 10.2146/ajhp050523.
8
Comparison of moxifloxacin and levofloxacin in an epithelial disorder model using cultured rabbit corneal epithelial cell sheets.比较莫西沙星和左氧氟沙星在培养兔角膜上皮细胞片上皮障碍模型中的作用。
Graefes Arch Clin Exp Ophthalmol. 2012 Jul;250(7):1035-41. doi: 10.1007/s00417-011-1916-1. Epub 2012 Jan 27.
9
The effect of the fourth-generation fluoroquinolones on corneal reepithelialization after penetrating keratoplasty.第四代氟喹诺酮类药物对穿透性角膜移植术后角膜再上皮化的影响。
Cornea. 2005 Oct;24(7):833-6. doi: 10.1097/01.ico.0000157420.11448.d4.
10
Association between moxifloxacin ophthalmic solution and fungal infection in patients with corneal ulcers and microbial keratitis.莫西沙星滴眼液与角膜溃疡和微生物性角膜炎患者真菌感染之间的关联。
J Ocul Pharmacol Ther. 2009 Jun;25(3):279-84. doi: 10.1089/jop.2008.0047.

引用本文的文献

1
In-Class Cross-Reactivity among Hospitalized Patients with Hypersensitivity Reactions to Fluoroquinolones.住院患者对氟喹诺酮类药物过敏反应的体内交叉反应性。
Antimicrob Agents Chemother. 2023 Jun 15;67(6):e0037423. doi: 10.1128/aac.00374-23. Epub 2023 May 8.